International derivatives marketplace CME Group has posted a notice of disciplinary action against Jeong Taewon.
The Chief Regulatory Officer of CME Group’s Market Regulation Department issued a charge against Jeong Taewon for violating Rule 534. based on allegations that, from July 19, 2022, through September 27, 2022, Jeong knowingly placed buy and sell orders in the same product and expiration month, where he knew or reasonably should have known that the purpose of the orders was to avoid taking a bona fide market position exposed to market risk in the September 2022 E-mini S&P Options market.
On May 15, 2024, a Hearing Panel Chair of the CME Business Conduct Committee (BCC) first determined that Jeong, having failed to submit a written answer to the charges issued against him, was deemed to have admitted the charges. Jeong therefore waived his right to a hearing…
Read More